MRNA logo

Moderna, Inc.

MRNA
0.00
USD
+0.00+0.00%

Moderna, Inc. at a glance

Open MRNA on Vela

Moderna, Inc. (MRNA) is a Healthcare company in the Biotechnology industry, headquartered in Cambridge, MA, with about 4,700 employees. Its shares trade on NASDAQ, and its IPO date is December 7, 2018. With a market capitalization of $79.9 billion, MRNA is a large-cap stock.

It trades an average of 17.2 million shares a day.

In its latest reported quarter (results released July 31, 2026), Moderna, Inc. posted revenue of $145.0 million and earnings of -$1.97 per share, against estimates of $102.9 million and -$2.03.

Figures as of October 25, 2026, from market data providers. Descriptive only, not financial advice.

MRNA: Frequently asked questions

As of October 25, 2026, Moderna, Inc. has a market capitalization of $79.9 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.